Cargando…
Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years
OBJECTIVES: This study aimed to identify potential safety signals and adverse events following the primary Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccination series among children and adolescents aged 5 to 17 years in the Republic of Korea. METHODS: Adverse events reported through the C...
Autores principales: | Kim, Seontae, Heo, Yeseul, Seo, Soon-Young, Lim, Do Sang, Cho, Enhi, Lee, Yeon-Kyeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Disease Control and Prevention Agency
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633262/ https://www.ncbi.nlm.nih.gov/pubmed/36328243 http://dx.doi.org/10.24171/j.phrp.2022.0233 |
Ejemplares similares
-
Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers
por: Im, Jae Hyoung, et al.
Publicado: (2021) -
Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine
por: Green, Manfred S, et al.
Publicado: (2022) -
Pfizer-BioNTech COVID-19 vaccine safe in older Koreans
Publicado: (2021) -
Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
Publicado: (2021) -
Focal segmental glomerulosclerosis following the Pfizer-BioNTech COVID-19 vaccine
por: Lim, Cho A, et al.
Publicado: (2022)